7Baggers
 bicycle therapeutics (nasdaq:bcyc) trading up 7.8% - here's why  MarketBeat Wed, 24 Sep 2025 19:39:30 GMT
 published on: 2025-09-16 16:15:02  khodrobank.com Tue, 16 Sep 2025 12:49:20 GMT
 bicycle therapeutics at the double with new board directors  Business Weekly Tue, 09 Sep 2025 08:35:34 GMT
 Analysts Positive on Bicycle Therapeutics (BCYC) After Q2 Results  Yahoo Finance Mon, 08 Sep 2025 07:00:00 GMT
 Bicycle Therapeutics Expands Board with New Appointments  TipRanks Mon, 08 Sep 2025 07:00:00 GMT
 Bicycle Therapeutics at the double with new board directors  Business Weekly Mon, 08 Sep 2025 07:00:00 GMT
 Bicycle Therapeutics appoints oncology veterans Dansey and Hoppenot to board  Investing.com Nigeria Mon, 08 Sep 2025 07:00:00 GMT
 analysts positive on bicycle therapeutics (bcyc) after q2 results  Yahoo Finance Sun, 07 Sep 2025 07:00:00 GMT
 layoff tracker: ac immune to cut 30% of workforce  BioSpace Fri, 05 Sep 2025 07:00:00 GMT
 published on: 2025-08-31 12:22:35  beatles.ru Sun, 31 Aug 2025 15:16:21 GMT
 published on: 2025-08-23 16:47:40  Newser Sat, 23 Aug 2025 21:47:40 GMT
 published on: 2025-08-21 23:44:36  더경남뉴스 Thu, 21 Aug 2025 16:19:08 GMT
 published on: 2025-08-21 16:43:10  beatles.ru Thu, 21 Aug 2025 13:43:51 GMT
 layoff tracker: csl cuts thousands in major restructuring  BioSpace Thu, 21 Aug 2025 07:00:00 GMT
 layoff tracker: opthea slashes 80% of workforce, 50% of board  BioSpace Wed, 20 Aug 2025 20:48:18 GMT

Bicycle Therapeutics plc
(NASDAQ:BCYC) 

BCYC stock logo

Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express...

Founded: 2009
IPO Price: $14 (May 23, 2019)
Full Time Employees: 81
CEO: Kevin Lee  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends